ID

30502

Descrição

Antidepressant Incomplete Response Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00782964

Link

https://clinicaltrials.gov/show/NCT00782964

Palavras-chave

  1. 09/06/2018 09/06/2018 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

9 de junho de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Major Depressive Disorder NCT00782964

Eligibility Major Depressive Disorder NCT00782964

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of written inform consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
diagnosed of major depressive disorder based on dsm-iv-tr
Descrição

Major Depressive Disorder

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1269683
outpatient who has a change in pharmacological therapeutic plan after an incomplete response or intolerance to a treatment with an adequate dosage of an antidepressant (ssri/nsri) 5
Descrição

Outpatients | Pharmacotherapy Plan Change | Status post Partial response | Intolerance to Antidepressive Agents Dosage | Intolerance to Selective Serotonin Reuptake Inhibitors | Intolerance to Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2,1]
C0013216
UMLS CUI [2,2]
C1301732
UMLS CUI [2,3]
C0443172
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1521726
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0003289
UMLS CUI [4,3]
C0178602
UMLS CUI [5,1]
C1744706
UMLS CUI [5,2]
C0360105
UMLS CUI [6,1]
C1744706
UMLS CUI [6,2]
C1579361
able to understand and to comply with requirements of the study
Descrição

Protocol Compliance

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
mental retardation
Descrição

Mental Retardation

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0025362
to have been recruited in a clinical trial in the last 4 weeks or to have planned the inclusion in a clinical trial during the follow-up of this study
Descrição

Study Subject Participation Status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348568
mdd secondary to substance abuse or somatic illness
Descrição

Major Depressive Disorder Secondary to Substance Use Disorders | Major Depressive Disorder Secondary to Illness Somatic

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1269683
UMLS CUI [1,2]
C0175668
UMLS CUI [1,3]
C0038586
UMLS CUI [2,1]
C1269683
UMLS CUI [2,2]
C0175668
UMLS CUI [2,3]
C0221423
UMLS CUI [2,4]
C2986476
actual depressive episode with <4 weeks or >12 months of length
Descrição

Depressive episode Duration

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0349217
UMLS CUI [1,2]
C0449238
current treatment with >1 ssri/srni or previous treatment with >1 ssri/srni, augmentation treatment with ssri/srni, intravenous antidepressant treatment, tms, ect or mao
Descrição

Selective Serotonin Reuptake Inhibitors Quantity | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) Quantity | Selective Serotonin Reuptake Inhibitors augmented | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) augmented | Antidepressive Agents Intravenous | Transcranial magnetic stimulation | Electroconvulsive Therapy | Monoamine Oxidase Inhibitors

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0360105
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1579361
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C0360105
UMLS CUI [3,2]
C0205217
UMLS CUI [4,1]
C1579361
UMLS CUI [4,2]
C0205217
UMLS CUI [5,1]
C0003289
UMLS CUI [5,2]
C1522726
UMLS CUI [6]
C0436548
UMLS CUI [7]
C0013806
UMLS CUI [8]
C0026457

Similar models

Eligibility Major Depressive Disorder NCT00782964

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
provision of written inform consent
boolean
C0021430 (UMLS CUI [1])
Major Depressive Disorder
Item
diagnosed of major depressive disorder based on dsm-iv-tr
boolean
C1269683 (UMLS CUI [1])
Outpatients | Pharmacotherapy Plan Change | Status post Partial response | Intolerance to Antidepressive Agents Dosage | Intolerance to Selective Serotonin Reuptake Inhibitors | Intolerance to Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Item
outpatient who has a change in pharmacological therapeutic plan after an incomplete response or intolerance to a treatment with an adequate dosage of an antidepressant (ssri/nsri) 5
boolean
C0029921 (UMLS CUI [1])
C0013216 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0443172 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C1521726 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C0003289 (UMLS CUI [4,2])
C0178602 (UMLS CUI [4,3])
C1744706 (UMLS CUI [5,1])
C0360105 (UMLS CUI [5,2])
C1744706 (UMLS CUI [6,1])
C1579361 (UMLS CUI [6,2])
Protocol Compliance
Item
able to understand and to comply with requirements of the study
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Mental Retardation
Item
mental retardation
boolean
C0025362 (UMLS CUI [1])
Study Subject Participation Status
Item
to have been recruited in a clinical trial in the last 4 weeks or to have planned the inclusion in a clinical trial during the follow-up of this study
boolean
C2348568 (UMLS CUI [1])
Major Depressive Disorder Secondary to Substance Use Disorders | Major Depressive Disorder Secondary to Illness Somatic
Item
mdd secondary to substance abuse or somatic illness
boolean
C1269683 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
C0038586 (UMLS CUI [1,3])
C1269683 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0221423 (UMLS CUI [2,3])
C2986476 (UMLS CUI [2,4])
Depressive episode Duration
Item
actual depressive episode with <4 weeks or >12 months of length
boolean
C0349217 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Selective Serotonin Reuptake Inhibitors Quantity | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) Quantity | Selective Serotonin Reuptake Inhibitors augmented | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) augmented | Antidepressive Agents Intravenous | Transcranial magnetic stimulation | Electroconvulsive Therapy | Monoamine Oxidase Inhibitors
Item
current treatment with >1 ssri/srni or previous treatment with >1 ssri/srni, augmentation treatment with ssri/srni, intravenous antidepressant treatment, tms, ect or mao
boolean
C0360105 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1579361 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0360105 (UMLS CUI [3,1])
C0205217 (UMLS CUI [3,2])
C1579361 (UMLS CUI [4,1])
C0205217 (UMLS CUI [4,2])
C0003289 (UMLS CUI [5,1])
C1522726 (UMLS CUI [5,2])
C0436548 (UMLS CUI [6])
C0013806 (UMLS CUI [7])
C0026457 (UMLS CUI [8])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial